Robert Metz BA

Mr. Metz joined Horizon Pharma in 2009 as the vice president global business operations and general manager Europe. He is responsible for the administration of global business operations and corporate external affairs including patient advocacy. Mr. Metz has over 27 years of commercial, external affairs, finance, administration and operations experience in both small and large pharmaceutical and biotechnology organizations. Prior to joining Horizon Pharma, Mr. Metz’s most recent position was vice president, commercial operations for IDM Pharma who manufactured MEPACT® for pediatric osteosarcoma. Mr. Metz played a key role in the turnaround and eventual sale of IDM Pharma to Takeda Pharmaceuticals in June 2009. He led commercial efforts, including development of key opinion leader and institution center outreach, patient advocacy relations and pricing and reimbursement programming throughout pan-European markets. Prior to joining IDM Pharma, Mr. Metz led commercial operations for NeoPharm, a public rare disease oncology biotechnology company with a phase 3 compound for glioblastoma multiforme.

For nearly 13 years, Mr. Metz worked in areas of increasing responsibility at Searle and Pharmacia focusing on product introductions on several products, including Celebrex®, Arthrotec®, Daypro® and Detrol LA®. His professional experience encompassed sales, business analysis, business development, commercial operations, human resources, information technology, project management, government, public and external affairs and real estate management. In his commercial management roles, Mr. Metz directed multifunctional, operational and performance aspects of sales organizations spanning over 650 sales and support employees with overall sales totaling over $2 billion. Mr. Metz has also held sales and marketing positions at Medpointe Pharma and Reliable Biopharmaceuticals. Mr. Metz has a bachelor’s degree in management/economics with a minor in political science from Marietta College in Marietta, OH.